Container closures are critical to ensure sterility of drug products. Physical, chemical, and biological assessments must be made to ensure components are compatible and fit for use. Additionally, USP <661.1>, <661.2>, & <382> will be official by end of year 2025.

This webinar will review the changes these new general chapters bring.

By attending the webinar you will learn:

• Container closure requirements for parenteral products
• What changes are brought with USP <661.1>, <661.2>, & <382>
• Nelson Lab’s capabilities to meet new chapter requirements